CN112675360B - Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold - Google Patents
Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold Download PDFInfo
- Publication number
- CN112675360B CN112675360B CN202011463467.1A CN202011463467A CN112675360B CN 112675360 B CN112675360 B CN 112675360B CN 202011463467 A CN202011463467 A CN 202011463467A CN 112675360 B CN112675360 B CN 112675360B
- Authority
- CN
- China
- Prior art keywords
- gelatin
- hadscs
- composite scaffold
- solution
- electrostatic spinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 81
- 239000000017 hydrogel Substances 0.000 title claims abstract description 60
- 239000011664 nicotinic acid Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 108010010803 Gelatin Proteins 0.000 claims abstract description 110
- 239000008273 gelatin Substances 0.000 claims abstract description 110
- 229920000159 gelatin Polymers 0.000 claims abstract description 110
- 235000019322 gelatine Nutrition 0.000 claims abstract description 110
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 110
- 239000012528 membrane Substances 0.000 claims abstract description 98
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 58
- 238000004132 cross linking Methods 0.000 claims abstract description 42
- 210000000130 stem cell Anatomy 0.000 claims abstract description 31
- 238000011068 loading method Methods 0.000 claims abstract description 15
- 239000006285 cell suspension Substances 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 5
- 239000000835 fiber Substances 0.000 claims description 89
- 239000000243 solution Substances 0.000 claims description 87
- 210000004027 cell Anatomy 0.000 claims description 57
- 239000008055 phosphate buffer solution Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 23
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 21
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 14
- 238000004140 cleaning Methods 0.000 claims description 12
- -1 bipyridyl ruthenium Chemical compound 0.000 claims description 10
- 239000006143 cell culture medium Substances 0.000 claims description 10
- 238000005286 illumination Methods 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000009987 spinning Methods 0.000 claims description 7
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 claims description 6
- 229920002799 BoPET Polymers 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 claims description 6
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 5
- 108010019160 Pancreatin Proteins 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229940055695 pancreatin Drugs 0.000 claims description 5
- 235000012730 carminic acid Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 230000029087 digestion Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 230000003592 biomimetic effect Effects 0.000 claims 6
- 208000027418 Wounds and injury Diseases 0.000 abstract description 56
- 206010052428 Wound Diseases 0.000 abstract description 55
- 210000001519 tissue Anatomy 0.000 abstract description 18
- 230000009286 beneficial effect Effects 0.000 abstract description 10
- 210000004204 blood vessel Anatomy 0.000 abstract description 9
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 230000035699 permeability Effects 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 6
- 239000001301 oxygen Substances 0.000 abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 abstract description 6
- 230000035755 proliferation Effects 0.000 abstract description 6
- 230000029663 wound healing Effects 0.000 abstract description 6
- 102000008186 Collagen Human genes 0.000 abstract description 5
- 108010035532 Collagen Proteins 0.000 abstract description 5
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 5
- 229920001436 collagen Polymers 0.000 abstract description 5
- 210000001126 granulation tissue Anatomy 0.000 abstract description 5
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 230000009545 invasion Effects 0.000 abstract description 3
- 230000005012 migration Effects 0.000 abstract description 3
- 238000013508 migration Methods 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 3
- 230000035899 viability Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 36
- 239000011521 glass Substances 0.000 description 29
- 241000700159 Rattus Species 0.000 description 17
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 12
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000008595 infiltration Effects 0.000 description 6
- 238000001764 infiltration Methods 0.000 description 6
- 239000002121 nanofiber Substances 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 238000000465 moulding Methods 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000021164 cell adhesion Effects 0.000 description 4
- 238000001523 electrospinning Methods 0.000 description 4
- 238000012014 optical coherence tomography Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000033115 angiogenesis Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000755266 Kathetostoma giganteum Species 0.000 description 2
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 238000005206 flow analysis Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002062 molecular scaffold Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002407 tissue scaffold Substances 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011463467.1A CN112675360B (en) | 2020-12-11 | 2020-12-11 | Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011463467.1A CN112675360B (en) | 2020-12-11 | 2020-12-11 | Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112675360A CN112675360A (en) | 2021-04-20 |
CN112675360B true CN112675360B (en) | 2022-03-04 |
Family
ID=75449314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011463467.1A Active CN112675360B (en) | 2020-12-11 | 2020-12-11 | Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112675360B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115869453A (en) * | 2021-09-26 | 2023-03-31 | 中国科学院理化技术研究所 | Double-layer antibacterial dressing loaded with antibacterial molecules, preparation and application |
CN114028603B (en) * | 2021-11-02 | 2022-11-25 | 太原理工大学 | Double-layer asymmetric dressing for promoting skin wound repair and preparation method thereof |
CN114870089B (en) * | 2022-01-17 | 2023-04-28 | 中国人民解放军联勤保障部队第九八八医院 | PCL-collagen/Gelma dual-radial composite stent loaded with MSCs and application |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361990B (en) * | 2008-09-03 | 2012-09-19 | 陕西瑞盛生物科技有限公司 | Double layer artificial skin and preparation method thereof |
WO2013109642A1 (en) * | 2012-01-16 | 2013-07-25 | Marshall University Research Corporation | Nanofiber scaffolds and methods for repairing damaged cardiac tissue |
KR101380780B1 (en) * | 2012-02-09 | 2014-04-02 | 순천향대학교 산학협력단 | Fabrication Method of Bilayer Scaffold For Skin Tissue |
CN108379664A (en) * | 2018-03-06 | 2018-08-10 | 广东工业大学 | It is a kind of to be used to build two-layer compound holder of full thickness skin and preparation method thereof |
CN109529123B (en) * | 2018-11-08 | 2021-02-19 | 中国人民解放军第四军医大学 | Vascularized full-layer tissue engineering skin formed by assembling hydrogel, nanofiber scaffold and skin cells layer by layer and preparation method thereof |
CN109125799A (en) * | 2018-09-05 | 2019-01-04 | 张强 | GelMA hydrogel people takes off the preparation method of the three-dimensional double-deck auxiliary material of cell amnion |
-
2020
- 2020-12-11 CN CN202011463467.1A patent/CN112675360B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN112675360A (en) | 2021-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112569399B (en) | Photo-crosslinking/electrostatic spinning preparation and application of hydrogel composite scaffold with double-layer skin structure | |
CN112675360B (en) | Preparation and application of hADSCs-loaded double-layer skin bionic hydrogel composite scaffold | |
Zhang et al. | Layered nanofiber sponge with an improved capacity for promoting blood coagulation and wound healing | |
CN109735434B (en) | Artificial tissue precursors and methods of making the same | |
Nseir et al. | Biodegradable scaffold fabricated of electrospun albumin fibers: mechanical and biological characterization | |
CN106267315B (en) | A kind of wound repair dressing | |
Wang et al. | Cross-linked collagen–chondroitin sulfate–hyaluronic acid imitating extracellular matrix as scaffold for dermal tissue engineering | |
CN103705984A (en) | Preparation method and application of collagen scaffold composite bone marrow-derived mesenchymal stem cells (BMSCs) | |
CN110200922A (en) | A kind of preparation method and application of gelatine microsphere | |
Tavakoli et al. | Coaxial electrospun angiogenic nanofiber wound dressing containing advanced platelet rich-fibrin | |
CN104254341B (en) | Medicament slow-released carrier | |
CN109381732A (en) | Electrostatic spinning dressing, preparation method and the application of growth factor-loaded micromolecular inhibitor | |
CN109481737A (en) | Bionical double-deck dressing of one kind and preparation method thereof | |
CN108261557B (en) | Nanofiber membrane for wound healing and preparation method and application thereof | |
CN106178063B (en) | A kind of no immunological rejection adhesive bandage | |
Lin et al. | Development and Evaluation of Multistructured and Hierarchical Epidermal Growth Factor-Poly ($\varepsilon $-Caprolactone) Scaffolds | |
CN110179760A (en) | A kind of gelatine microsphere and its preparation method and application loading rADSCs | |
Liu et al. | Preparation and evaluation of a silk fibroin–polycaprolactone biodegradable biomimetic tracheal scaffold | |
CN111529125B (en) | Tissue engineering blood vessel patch manufacturing template and tissue engineering blood vessel patch | |
CN111467576B (en) | Artificial gallbladder wall synthetic material, preparation method and application thereof, and artificial gallbladder wall | |
CN109876187B (en) | Tissue engineering cartilage repairing scaffold using globular protein as pore-forming agent and preparation method thereof | |
CN114832149A (en) | Wound dressing based on stem cell micro-embedded composite hydrogel and preparation method thereof | |
Cirulli et al. | Hydrogels as tissue barriers | |
Kang | Biofabricated platforms for wound healing and skin regeneration | |
CN115337222A (en) | Hollow collagen structure body and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220914 Address after: C406, Engineering College Building, East Campus of Sun Yat-sen University, Panyu District, Guangzhou City, Guangdong Province, 510006 Patentee after: SUN YAT-SEN University Patentee after: Shenzhen, Zhongshan University Address before: 510000 School of engineering, East Campus of Sun Yat sen University, Panyu District, Guangzhou City, Guangdong Province, b515 Patentee before: SUN YAT-SEN University |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 518107 No. 66, gongchang Road, Guangming District, Shenzhen, Guangdong Patentee after: Shenzhen, Zhongshan University Patentee after: SUN YAT-SEN University Address before: C406, Engineering College Building, East Campus of Sun Yat-sen University, Panyu District, Guangzhou City, Guangdong Province, 510006 Patentee before: SUN YAT-SEN University Patentee before: Shenzhen, Zhongshan University |
|
CP03 | Change of name, title or address |